Mesilate

基本解釋

Conclusion The result suggest that gabexate mesilate may possibly prevent post-ERCP pancreatitis and hyperamylasemia.
結(jié)論加貝酯能有效預(yù)防ERCP術(shù)后高淀粉酶血癥及急性胰腺炎的發(fā)生。
Aim To observe and compare the efficacy of ulinastatin(UTI) and gabexate mesilate(GM) on treating acute pancreatitis.
目的對比烏司他丁和加貝酯對急性胰腺炎的療效。
In the haemolytic test, tubes with pazufloxacin mesilate didn't see haemolytic reaction, but tube for comparison did.
溶血試驗(yàn)中甲磺酸帕珠沙星注射液各試管均無溶血現(xiàn)象發(fā)生，而對照管發(fā)生溶血。
OBJECTIVE To establish the best preparation technology of pazufloxacin mesilate drop pills.
目的確立甲磺酸帕珠沙星滴丸的最佳制備工藝。
Objective To investigate the effects of gabexate mesilate on avoiding the hyperamylasemia and the acute pancreatitis.
目的觀察加貝酯在預(yù)防ERCP術(shù)后引起的高淀粉酶血癥和急性胰腺炎的有效性。